Improving the effectiveness of eradication therapy for Helicobacter pylori infection
Background. Butyric acid (butyrate) is a short-chain fatty acid produced by anaerobic bacteria of the species Eubacterium rectale, Eubacterium ramulus, Eubacterium hallii, Roseburia cecicola, Roseburia faecis, Faecalibacterium prausnitzii and Coprococcus faecalis, as well as Fusobacteria, non-pathog...
Saved in:
Main Authors: | E. A. Ljaljukova, E. N. Chernysheva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Open Systems Publication
2024-12-01
|
Series: | Лечащий Врач |
Subjects: | |
Online Access: | https://journal.lvrach.ru/jour/article/view/1333 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Compliance with Helicobacter pylori eradication: modern approaches to increase in commitment and the results of own research
by: T. A. Ilchishina
Published: (2021-06-01) -
Improving the effectiveness of H. pylori eradication therapy: focus on patient compliance and treatment safety
by: M. D. Ardatskaya, et al.
Published: (2021-06-01) -
Benefits of Helicobacter pylori Eradication on Extragastric Diseases
by: Tae Jun Kim, et al.
Published: (2021-12-01) -
Efficiency of ursodeoxycholic acid in the frameworks of minimization of hepatotoxic potential of eradication therapy of Helicobacter pylori infection
by: D. N. Andreev, et al.
Published: (2021-06-01) -
New Approaches to Therapy of Helicobacter pylori Infection (by the Materials of the Maastricht Consensus-IV, Florence, 2010)
by: A. G. Evdokimova, et al.
Published: (2020-05-01)